Patients with cancer, who’ve had at least one previous treatment and whose tumor tissue shows a specific genetic mutation, could be eligible for one of many clinical trials each testing a novel oral agent.
Investigator: Bill G Schmidt, MD
Status: Recruiting
Phase: 2
Sponsor: Novartis Pharmaceuticals
Contact: Christine Reed, 541-706-6592 or creed@bmctotalcare.com
Location: Bend, Oregon (Central Oregon)
Click on the links below to see details of the included individual trials at ClinicalTrials.gov:
NCT01981187
NCT02002689
NCT01833169
NCT01831726
NCT01885195
NCT02186821
NCT02187783
NCT02160041
For general inquiries, please contact the BMC Research Department at research@bmctotalcare.com or 877-692-8338.
What an enlightening article! It provided a lot of food for thought. Let’s discuss this further. Click on my nickname for more!